The study looked at the potential benefits of cataract surgery in patients with a prior diagnosis of optic neuropathy. Patients with and without optic neuropathies showed significant improvement in ...

A 71-year-old man was referred by his usual ophthalmologist to the neuro-ophthalmology clinic at Tufts Medical Center for bilateral decreased vision associated with bilateral optic disc edema. His ...

"Our decision to treat typically needs to be made on the balance of likelihood, before the diagnosis of an associated disease process can be fully established, with definitive tests for multiple ...

Please provide your email address to receive an email when new articles are posted on . One physician said intravenous corticosteroids are useful for treating optic neuritis. Another argued ...

Ophthalmologists, optometrists, and neurologists may be widely overdiagnosing optic neuritis, researchers say. Neuro-ophthalmologists at Washington University in St Louis, Missouri, could confirm only ...

A nationwide cohort study of more than 4 million adults showed that people with allergic diseases were nearly one third more likely to develop optic neuritis than those without such conditions, with ...

DUBLIN--(BUSINESS WIRE)--The "Optic Neuritis - Pipeline Review, H2 2019" drug pipelines has been added to ResearchAndMarkets.com's offering. This report provides comprehensive information on the ...

A new therapeutic agent tested in a mouse model of multiple sclerosis (MS) produced anti-inflammatory activity and prevented loss of cells in the optic nerve, according to a new study by researchers ...

Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...

Optic neuritis (ON) is characterized by inflammation of the optic nerve with acute loss of vision in one eye. It is among the initial manifestations of multiple sclerosis (MS) and occurs secondary to ...

Oculis Announces Positive OCS-05 Phase 2 ACUITY Trial in Acute Optic Neuritis, Met Primary Safety Endpoint and Key Secondary Efficacy Endpoints Opening Development Pathways as a Potential ...